Abstract:Objective: To study the tumor-selective replication, cytotoxicity and GM-CSF production of the recombinant virus in KH901 injection used to infect the cells cultured in vitro. Methods: A panel of tumor and normal cells was infected with recombinant adenovirus in KH901 and wild-type adenovirus type 5 at a MOI of 2 PPC, the cells were harvested at 72 hours after infection and made a titer after three cycles of freeze/thaw; A panel of tumor and normal cells was infected with recombinant adenovirus KH901 at MOI of 1 or 10 PPC. For 24 hours after infection the medium was harvested to determine the biological activity of GM-CSF; A panel of tumor and normal cells was infected with KH901 of recombinant adenovirus and wild-type adenovirus type 5 at MOIs of 0, 0.1, 1, 10, 100, and 1000 PPC. At 7 days after infection, cell viability was determined by the MTT assay, and ECso was determined too. Results: The data showed that wild-type adenovirus type 5 replicated efficiently in and killed both the tumor and normal cells, however, the recombinant adenovirus in KH901 replicated hugely in tumor cells [(2526.4+/-136.8)-(2796.6+/-104.6) TCID50/cell), and produced significant amount of GM-CSF [(1177. 793 +/-6.62)-(3924.497+/-17.79) IU/(10(6) cell x 24h)] and killed the tumor cells [EC50: (0.31+/-0.06)-(0.19+/- 0.01) pfu/cell] while was replicating poorly in non-permissive human normal cells [(56.8+/-9.2)-(90.1+/-14.4) TCID50/ cell], and producing very small amount of GM-CSF [(13.397+/-0.82) IU/(10(6)cell x 24 h)] and attenuating human primary cells killed [EC50: (92.33 +/- 9.12)-(121.20 +/- 19.94) pfu/cell], with which there was statistically a significant difference between wild-type adenovirus type 5 and recombinant adenovirus in KH901 (P<0.05). Conclusion: In vitro studies show that the tumor-selective replication, cytotoxicity, GM-CSF production of recombinant adenovirus lead the injection KH901 containing the recombinant adenovirus, as oncolytic agent, to have a potential utility for the treatment of solid tumors.

Construction of Recombinant Adenovirus Ad-CMV-TK and Its Inhibitory Effect on Lewis Cells

Adenovirus Vector Mediated HSV-tk Gene Killing Action on Lewis Lung Cancer Cells

Construction of Recombinant Adenovirus Containing TK Gene and Its Effect Against Human Liver Cancer Cells

[Experimental Study on Human Pulmonary Adenocarcinoma Cell A549 Transfected with HSV₁-TK Gene in Vitro and in Vivo].

[Antitumor Effect of Recombinant T7 Phage Vaccine Expressing Xenogenic Vascular Endothelial Growth Factor on Lewis Lung Cancer in Mice].

Study of Adenoviral-Mediated Gene Therapy for Bladder Cancer Cell

Antitumor Effect of HSV-TK Gene with Adenovirus Mediation on Alimentary Carcinoma

Immunotherapy effect on tumor and recombination of VGFR phage vaccine

Construction of Recombinant Adenovirus Containing tk Gene

In vitro antitumor effect of CD, TK fusion suicide gene induced by adenovirus vector

Effect of Recombinant Adenovirus Expressing CD/TK Double Suicide Genes on Proliferation of Vascular Smooth Muscle Cells

In Vivo Antitumor Activity of HSV-tk/CD Combinative Gene Toward Human Cholangiocarcinoma Cells(QBC939)

[Construction and Identification of Recombinant Vectors Carrying Herpes Simplex Virus Thymidine Kinase Genes Expressed in Vascular Endothelial Cells].

Study of Adenovirus-Mediated HSV-tk Gene Therapy for Bladder Cancer Cell Line

Construction of eukaryotic expression vector containing HSV-TK and IL-2 double genes and its expression in human pulmonary adenocarcinoma cell A549.

[The Effect of HSV-tk/GCV on Hepatic Specific Damage Driven by Murine ALB Promoter/enhancer].

Construction and Expression of Bicistronic Adenovirus Vector Carrying Thymidine Kinase and Enhanced Green Fluorescent Protein Gene.

Therapeutic Mechanism of Adenovirus Mediated HSV-TK/GCV for Oral Squamous Carcinoma Cells in Vitro

Adenovirus vector-mediated herpes simplex virus-thymidine kinase gene/ganciclovir system exhibits anti-tumor effects in an orthotopic hepatocellular carcinoma model.

Expression of thymidine kinase driven by an endothelial-specific promoter inhibits tumor growth of Lewis lung carcinoma cells in transgenic mice

[Tumor-selective replication, cytotoxicity and GM-CSF production of oncolytic recombinant adenovirus in KH901 injection]